Chemotherapeutic assessment and approaches

Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas.

Sarcoma·2008

Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas.

Gene therapy·2005

Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group Study.

Cancer investigation·2001

Calcified left ventricular mass: unusual clinical, echocardiographic, and computed tomographic findings of primary cardiac osteosarcoma.

Mayo Clinic proceedings·2000

Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome.

Cancer·1999

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.

British journal of cancer·1998

Investigation of FLASH Proton Radiation Induced DNA Double Strand Breaks in Plasmid DNA Using Atomic Force Microscopy.

International journal of radiation oncology, biology, physics·2026

Real-world data on once or twice daily radiotherapy and the effect of age in patients with limited-stage small cell lung cancer.

International journal of radiation oncology, biology, physics·2026

Long-Term Outcomes of Advanced Pneumatic Compression Device vs. Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical Trial.

International journal of radiation oncology, biology, physics·2026

LncDNAH5 Regulates Radiotherapy-Induced Toxicity via MDM2-Mediated Degradation of TP53BP1.

International journal of radiation oncology, biology, physics·2026

Interobserver Agreement in Acute Toxicity Assessment During Head and Neck Radiotherapy/Chemoradiotherapy: Implications for Endpoint Selection in Clinical Trials.

International journal of radiation oncology, biology, physics·2026

Carbon Ion Radiation Therapy of Sacrococcygeal Chordomas: A Comparison of Different Fractionation Schemes.

International journal of radiation oncology, biology, physics·2026

Escin ameliorates letrozole-induced polycystic ovarian syndrome by modulating inflammatory, oxidative stress, and steroidogenic pathways in Wistar rats: integration of network pharmacology and molecular docking.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Harmine reduces ROS-mediated hepatotoxicity in a cisplatin mouse model.

Research in pharmaceutical sciences·2026

Patient knowledge, practices, and adherence to oral anticancer medicines: Evidence from oncology clinics, National Hospital, Galle, Sri Lanka.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Why do bisphosphonates work in the treatment of CRPS? A translational pharmacological perspective to solve a conundrum.

Expert review of clinical pharmacology·2026

Developing a Symptom Toolkit for Adult Lymphoma Patients Receiving Chemotherapy in Malawi.

Palliative medicine reports·2026

Metal Chelation Following Inappropriate Testing: Approach to Non-Medically Indicated Therapy Requests : Ethics in Practice.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026

Related Experiment Videos

Chemotherapeutic assessment and approaches

Related Concept Videos

Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas.

Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas.

Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group Study.

Calcified left ventricular mass: unusual clinical, echocardiographic, and computed tomographic findings of primary cardiac osteosarcoma.

Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome.

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.

Investigation of FLASH Proton Radiation Induced DNA Double Strand Breaks in Plasmid DNA Using Atomic Force Microscopy.

Real-world data on once or twice daily radiotherapy and the effect of age in patients with limited-stage small cell lung cancer.

Long-Term Outcomes of Advanced Pneumatic Compression Device vs. Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical Trial.

LncDNAH5 Regulates Radiotherapy-Induced Toxicity via MDM2-Mediated Degradation of TP53BP1.

Interobserver Agreement in Acute Toxicity Assessment During Head and Neck Radiotherapy/Chemoradiotherapy: Implications for Endpoint Selection in Clinical Trials.

Carbon Ion Radiation Therapy of Sacrococcygeal Chordomas: A Comparison of Different Fractionation Schemes.

Escin ameliorates letrozole-induced polycystic ovarian syndrome by modulating inflammatory, oxidative stress, and steroidogenic pathways in Wistar rats: integration of network pharmacology and molecular docking.

Harmine reduces ROS-mediated hepatotoxicity in a cisplatin mouse model.

Patient knowledge, practices, and adherence to oral anticancer medicines: Evidence from oncology clinics, National Hospital, Galle, Sri Lanka.

Why do bisphosphonates work in the treatment of CRPS? A translational pharmacological perspective to solve a conundrum.

Developing a Symptom Toolkit for Adult Lymphoma Patients Receiving Chemotherapy in Malawi.

Metal Chelation Following Inappropriate Testing: Approach to Non-Medically Indicated Therapy Requests : Ethics in Practice.

Related Experiment Videos

Chemotherapeutic assessment and approaches

Related Concept Videos

Related Articles